Two prominent leaders in Orange County are advocating for innovative drug therapies to help individuals with PTSD, addiction, and mental illness.
This movement follows President Donald Trump’s recent executive order, which paves the way for alternative treatments using psychedelic drugs like psilocybin, MDMA, and ibogaine.
Congressman Lou Correa and veteran leader Nick Berardino are at the forefront of this initiative. They are working to establish an advisory committee to support companion House legislation that would formalize Trump’s executive order and provide guidelines and funding for these therapies. The committee, consisting of local leaders in various fields, held its first meeting in Anaheim, California, to discuss the legislation and gather input from the community.
Correa, a moderate Democrat, emphasizes that this effort is about public safety and addressing mental health challenges, not promoting counterculture. He co-founded the Congressional Psychedelics Advancing Therapies (PATH) Caucus with Republican Congressman Jack Bergman, advocating for psychedelic research and science.
The executive order signed by President Trump aims to accelerate access to psychedelic-assisted treatments, particularly for veterans struggling with PTSD and other mental health issues. The order directs the FDA to prioritize the review of psychedelic compounds and encourages collaboration between federal and state agencies. It also allocates $50 million for research and development of these therapies.
The initiative faces challenges, including skepticism from the Veterans Administration and some Democratic leaders. However, Correa and Berardino are optimistic about the potential of psychedelic therapies to revolutionize mental health treatment and address issues like veteran suicide and homelessness. They hope to build support within the community and collaborate with institutions like UC Irvine and the OC Health Care Agency to advance research and integration of these therapies.
As the legislation progresses, it could set a precedent for other regions and potentially lead to broader acceptance and implementation of psychedelic therapies across the United States.
Recent Comments